Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance by Justin R. Gregg, Lisa Newcomb, Ranran Wu, Jennifer Dennison, John W. Davis, Curtis Pettaway, Louis Pisters, John F. Ward, Brian F. Chapin, Lisly Chéry, Ahmet Urkmez, Andrew M. Fang, Noel Higgason, Patricia Troncoso, Carrie R. Daniel, Christopher Logothetis, Timothy C. Thompson, Andrew W. Hahn, Menghan Liu, Yingye Zheng, Dan W. Lin, Samir Hanash, Ehsan Irajizad, Johannes Fahrmann

Connect to this object online.